In some tumor cells, an increase in IFN‐γ has been demonstrated to induce an increase in IDO production,210 further promotes resistance to monoclonal antibody CTLA‐4 or PD‐1 treatment, leading to immune escape, which can be overcome by IDO inhibitors. Here, IDO1 is linked to neoplasm.